Aca-ac, Alexander A.

HRN: 15-92-78  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2025
CEFTAZIDIME 1GM (VIAL)
07/27/2025
08/05/2025
IV
1g
Q8h
T/C GI TB
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines